-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
UNITED THERAPEUTICS Corp quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- UNITED THERAPEUTICS Corp Operating Income (Loss) for the quarter ending September 30, 2024 was $343M, a 4.92% increase year-over-year.
- UNITED THERAPEUTICS Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.28B, a 16.3% increase year-over-year.
- UNITED THERAPEUTICS Corp annual Operating Income (Loss) for 2023 was $1.18B, a 20.9% increase from 2022.
- UNITED THERAPEUTICS Corp annual Operating Income (Loss) for 2022 was $980M, a 76.2% increase from 2021.
- UNITED THERAPEUTICS Corp annual Operating Income (Loss) for 2021 was $556M, a 6.35% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)